THOMPSON RAHSAAN (Chief Legal & Compliance) sold 30.1% of their position (34.56K shares) of ZEVRA THERAPEUTICS, INC. on the open market
Open‑market sale worth $438.3K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/23/2026ACC: 0001434647-26-000057
OfficerOther· Chief Legal & Compliance
Since Jan 2026
-34.56K
Net shares
Net seller
$438.3K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
66.67K acquired · 101.22K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+66.67K
Price / share
—
Trade value
—
% of position
138.5%
6/21/2026
48.13K→114.79K
Common Stock
Direct
Shares
−34.56K
Price / share
$12.68
Trade value
$438.30K
% of position
30.1%
6/22/2026
114.79K→80.23K
Total
Net shares
+32.11K
Net value
-$438.30K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/21/2026 | M · Option Exercise | +66.67K | — | — | 138.5% | 48.13K | 114.79K |
| Common Stock Direct | 6/22/2026 | S · Sale | −34.56K | $12.68 | $438.30K | 30.1% | 114.79K | 80.23K |
| Total | +32.11K | -$438.30K | ||||||
Derivative Transactions1
Restricted Stock Unit
Direct
Converts to
Common Stock
66.67K shares
Shares
−66.67K
Strike price
Held after
66.67K
Exercisable
—
6/21/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Unit Direct | Common Stock66.67K shares | 6/21/2026 | M · Option Exercise | −66.67K | — | 66.67K |